Condition: AI (Artificial Intelligence) · Pulmonary Nodule, Solitary · Pulmonary Nodule, Multiple · Sponsor: Nottingham University Hospitals NHS Trust
This study is a multi-centre prospective observational cohort study recruiting patients with 5-30mm solid and part-solid pulmonary nodules that have been detected on CT chest scans performed as part of routine practice. The aim is to determine whether physician decision making with the AI-based LCP tool, generates clinical and health-economic benefits over the current standard of care of these patients.
This description comes directly from the study's public registry record.
Contact details are listed per location below or on the registry record.
Always discuss trial participation with your own doctor first.
| Betsi Cadwaladr University Health Board | Bangor, United Kingdom | Recruiting |
| Frimley Health NHS Foundation Trust (Wexham Park Hospital) | Frimley, United Kingdom | Recruiting |
| Leeds Teaching Hospitals NHS Trust | Leeds, United Kingdom | Recruiting |
| King's College Hospital NHS Foundation Trust | London, United Kingdom | Recruiting |
| Royal Free Hospital | London, United Kingdom | Recruiting |
| St. George's University Hospitals NHS Foundation Trust | London, United Kingdom | Recruiting |
| The Royal Marsden NHS Foundation Trust | London, United Kingdom | Recruiting |
| University College London Hospitals NHS Foundation Trust | London, United Kingdom | Recruiting |
| Nottingham University Hospitals NHS Trust | Nottingham, United Kingdom | Recruiting |
| Oxford University Hospitals NHS Foundation Trust | Oxford, United Kingdom | Recruiting |
Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.
We email about this public record only. Unsubscribe anytime with one click. Never medical advice.
This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.
Source record: clinicaltrials.gov/study/NCT05389774